Ardent Health, Inc. (ARDT): who owns it and who trades it
As of Nov 16, 2026, ARDT insiders reported 2 purchases worth $186K in the last 12 months. The largest buyer was Robert DeMichiei (Director), with $98.3K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Ardent Health
From the latest filingsOverall: more buying than selling. Funds, insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ARDT
139 funds and institutions reported ARDT shares worth $1.1B at the end of Q2 2026, about 76% of the company. The largest holder is Chai Trust Co LLC with 54.1%.
Funds and institutions (13F) 76%Everyone else 24%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Chai Trust Co LLC | 77.25M | 54.06% | $760M | No change |
| Ventas, Inc. | 9.34M | 6.54% | $91.9M | No change |
| BlackRock, Inc. | 2.18M | 1.52% | $21.4M | +24% |
| Ameriprise Financial Inc | 2.11M | 1.48% | $20.8M | +19% |
| Goldentree Asset Management LP | 1.58M | 1.11% | $15.5M | -31% |
| AQR Capital Management LLC | 1.45M | 1.01% | $14.2M | +54% |
| CastleKnight Management LP | 1.08M | 0.75% | $10.6M | No change |
| Vanguard Capital Management LLC | 963,833 | 0.67% | $9.5M | -4% |
| Bridgeway Capital Management, LLC | 841,126 | 0.59% | $8.3M | -10% |
| Geode Capital Management, LLC | 620,947 | 0.43% | $6.1M | +11% |
| Algert Global LLC | 597,745 | 0.42% | $5.9M | +1277% |
| State Street Corp | 566,205 | 0.40% | $5.6M | -3% |
| First Trust Advisors LP | 562,278 | 0.39% | $5.5M | +17% |
| Empowered Funds, LLC | 551,293 | 0.39% | $5.4M | +3% |
| SageView Advisory Group, LLC | 480,447 | 0.34% | $4.7M | – |
| Hotchkis & Wiley Capital Management LLC | 444,896 | 0.31% | $4.4M | +1% |
| UBS Group AG | 442,619 | 0.31% | $4.4M | -2% |
| Bank of America Corp | 390,241 | 0.27% | $3.8M | +8% |
| Wedge Capital Management L L P | 327,242 | 0.23% | $3.2M | +212% |
| Morgan Stanley | 315,960 | 0.22% | $3.1M | +8% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ARDT insiders reported $186K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Robert DeMichiei | Director | Purchase | 11,260 | $8.73 | $98.3K | Form 4 |
| Jun 5, 2026 | Alfred Lumsdaine | CFO | Purchase | 10,000 | $8.81 | $88.1K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Robert DeMichiei | Director | $98.3K | – | Jun 5, 2026 |
| Alfred Lumsdaine | Chief Financial Officer | $88.1K | – | Jun 5, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ARDT short interest
Low short interest. 2.4% of ARDT shares are sold short: about 1 share in 41. Over the last 12 reports the number of shares short went up 20%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.45M ARDT shares were sold short, 2.4% of the shares outstanding, down 8.2% from the report before. At the average daily volume of 392,470 shares, buying them all back would take about 8.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.45M | 2.44% | -8% | 392,470 | 8.8 |
| Oct 15, 2026 | 3.75M | 2.66% | -19% | 549,347 | 6.8 |
| Sep 30, 2026 | 4.63M | 3.28% | +1% | 432,626 | 10.7 |
| Sep 15, 2026 | 4.58M | 3.24% | +17% | 466,519 | 9.8 |
| Aug 31, 2026 | 3.90M | 2.76% | -6% | 298,265 | 13.1 |
| Aug 14, 2026 | 4.14M | 2.94% | -4% | 454,075 | 9.1 |
| Jul 31, 2026 | 4.32M | 3.02% | -6% | 541,045 | 8.0 |
| Jul 15, 2026 | 4.61M | 3.23% | +3% | 550,938 | 8.4 |
| Jun 30, 2026 | 4.49M | 3.14% | +24% | 601,983 | 7.5 |
| Jun 15, 2026 | 3.63M | 2.54% | +20% | 758,698 | 4.8 |
| May 29, 2026 | 3.03M | 2.12% | +5% | 410,427 | 7.4 |
| May 15, 2026 | 2.88M | 2.01% | -7% | 479,540 | 6.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Ardent Health company events
Ardent Health filed 11 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Oct 23, 2026LeadershipAs previously disclosed, Martin J. Bonick’s employment as President and Chief Executive Officer of Ardent Health, Inc. and his service as a member of the Company’s Board of Directors ended effective June 2, 2026. Filing
- Sep 4, 2026AnnouncementThis Current Report on Form 8-K (this “Current Report”) is being filed by Ardent Health, Inc. to revise its non-GAAP financial measures and related disclosures included in “Item 7. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 30, 2026LeadershipAs previously disclosed, on June 2, 2026, Ardent Health, Inc. announced that Martin J. Bonick had departed from his role as President and Chief Executive Officer of the Company and had stepped down from the Company’s Board of Directors, effective as of the Effective Date. Filing
- Jun 2, 2026LeadershipThe Board of Directors of Ardent Health, Inc. appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board. Filing
- May 26, 2026VoteReported shareholder vote results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Mar 27, 2026LeadershipArdent Health, Inc. and Ethan Chernin determined that Mr. Chernin would no longer serve as President, Hospital Services and would depart the Company effective that day. Filing
- Mar 4, 2026ResultsReleased financial results. Filing
- Nov 18, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Ardent Health financials
Famous investors that hold ARDT
3 of the 50 well-known investors we track reported holding ARDT in their latest 13F filing. The largest position is Ken Griffin's, worth $2.7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 257,172 | $2.7M | 0.0% | +127% |
| Israel Englander · Millennium Management | Q3 2026 | 141,040 | $1.5M | 0.0% | +194% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 14,311 | $148K | 0.0% | -88% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Ardent Health, Inc. (ARDT) stock
Who owns the most ARDT stock?
The largest reported owner of Ardent Health, Inc. (ARDT) is Chai Trust Co LLC, with 54.1% of the company. In total, 139 funds and institutions reported holding ARDT at the end of Q2 2026, together about 76% of the shares. See the largest owners.
Are ARDT insiders buying or selling?
In the last 12 months, ARDT insiders reported 2 open-market purchases worth $186K and no sales. The latest trade was on Jun 5, 2026. See every trade.
What is the short interest in ARDT?
As of Oct 30, 2026, 3.45M ARDT shares were sold short, 2.4% of the shares outstanding, down 8.2% from the report before. At the average daily volume of 392,470 shares, buying them all back would take about 8.8 trading days (days to cover). See the history.
Which famous investors hold ARDT?
3 of the 50 well-known investors we track reported ARDT in their latest 13F filing, including Ken Griffin, Israel Englander, Steve Cohen. The largest position is worth $2.7M. See all holders.
Executive pay
Ardent Health's chief executive was paid a total of $6.1M for the year ended Dec 31, 2025, down 12% from $6.9M the year before. In the last 12 months, Ardent Health's executives and directors bought $186K of stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.